Announcement

Collapse
No announcement yet.

Surge in seasonal flu cases possible: CDC (Taiwan)

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Surge in seasonal flu cases possible: CDC (Taiwan)

    Surge in flu cases possible: CDC
    TAIPEI, Taiwan -- Public health officials have expressed concern over a possible surge in influenza cases due to flu virus mutations as people return to work and schools reopen next week. The Center for Disease Control (CDC) under the Department of Health confirmed 13 severe flu cases around Taiwan since the winter season started, including two girls aged three and 11 infected with the H1N1 strain of flu virus. Three have died due to flu related complications.
    The total number of flu cases under close monitoring by the CDC increased 14 percent from the previous week.
    Medical researchers said the flu virus normally undergoes minor modifications every year, with possible drastic mutations every five years.
    They said both the H1N1 and H3N2 strains of flu virus that hit Taiwan this time have undergone mutations, with the H1N1 strain of virus showing the most obvious changes, notably a strong resistance to the Tamiflu vaccine the government provided for the public since last fall.
    Both flu strains are prevalent across the island, although H1N1 is the dominant strain in northern and eastern Taiwan while H3N2 is the dominant strain in central and southern parts of the island.
    Some pharmacists say sales of anti-flu drugs have recently shot up by as much as 40 percent.
    Medical experts advise people, especially those in frequent contact with babies and the elderly, to constantly wash their hands with soap and avoid rubbing their eyes. Staying away from crowded public areas or places with inadequate ventilation will also reduce the likelihood of infection. Other effective measures to ward off the flu include drinking enough water, getting more rest, wearing face masks when outdoors, and putting off extreme physical exercise.
    Those who have a cold without a significant improvement after five days should seek medical treatment at a large hospital, the CDC added.


  • #2
    Re: Surge in flu cases possible: CDC (Taiwan)

    Comment


    • #3
      Re: Surge in flu cases possible: CDC (Taiwan)

      The figures cited in above commentary from the first-hand experience of dr Wu leave very few doubts about the current striking evolution and spread of A/(H1N1)-oseltamivir-resistant strain across Asia and elsewhere.

      This incidents should be taken seriously into account by international health officials and agencies, since the possible fall-out in pandemic preparedness antivirals stockpiles usefulness.

      Comment


      • #4
        Re: Surge in flu cases possible: CDC (Taiwan)



        Commentary

        H1N1 Oseltamivir Resistance in Taiwan During 2008-2009
        Recombinomics Commentary 08:44
        February 5, 2009



        In the past 3 weeks (January 11-31 2009), influenza activity increased rapidly in Taiwan. Currently, the influenza A/H1N1 viruses have become the predominant subtype, and H3N2 viruses also co-circulated. During 2007-2008 flu season, influenza A/H1N1 viruses predominantly circulated in Taiwan and the viruses were all sensitive to Oseltamivir. However, starting from September to December in 2008, an average of 46% resistance (22/48), with the H274Y mutation in the NA, was detected by Taiwan Centers for Disease Control (Taiwan CDC). The more detailed month-to-month proportion figures of resistant viruses are as follows: 0% (0/21) from January to August, 11.1 % (2/18) in September, 27.3 % (3/11) in October, 66.7 % (2/3) in November, and 100% (15/15) in December. It seems that there was a fast increasing trend of Oseltamivir resistance in Taiwan from September 2008.

        Ho-Sheng Wu, Ph.D.
        Director, Research and Diagnostic Center
        Director, National Influenza Center
        Centers for Disease Control, Taiwan

        Recombinomics thanks Dr Wu for the first hand knowledge on the evolving influenza situation in Taiwan.
        "The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation

        Comment


        • #5
          Re: Surge in seasonal flu cases possible: CDC (Taiwan)

          Emergence of variant strains of influenza virus vaccine dropped
          <TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD class=story_author align=middle width="75%">

          New Tang Dynasty TV www.ntdtv.com 2009-2-5 00:49
          </TD></TR></TBODY></TABLE>

          【New Tang Dynasty February 5, 2009讯】 people good health and recently much attention because the currently popular type of influenza A, including H1 and H3 virus strains mutate, so that the effect of influenza vaccine decreased the protective effect may have been discounted , as the H1 virus prevalence has been 3 years, physicians express very unusual to remind everyone, the next two weeks may be the peak period of influenza transmission, a special attention.

          Clinic full of people, the children are with friends from a mask, because everyone has been infected influenza.

          National Taiwan University Hospital, director of pediatric infection Li-Min Huang: "That the current CDC data also confirmed that Taiwan's current popular throughout Taiwan H1 viruses, genes have a considerable degree of mutations, so the previous two years received, generated by antibodies, probably no effects. "

          The original A-type influenza virus H1 variant, so that the influenza vaccine greatly reduced, and even clinical trials of drug Tamiflu has been 100% on H1 virus is invalid.

          Now including Taipei City and Taipei County, Taoyuan county, as well as in central and southern metropolitan area, are all experiencing an influenza pandemic situation, but the Department of Health stressed that the vaccine is still useful.

          Deputy Secretary for Disease Control: "laboratory which may have a comprehensive virus antibodies, part of the integrated virus, the effect of comparison will be affected, but the basis of clinical time to do in this area, or effective. Then, after playing the influenza vaccine, It can reduce 27 percent, because of influenza or pneumonia caused by the patient, it can reduce 48%, pneumonia or influenza deaths. "

          Vaccination by antibody, there were at least some protective effect, but the next week after the opening of cross-infection, it may also appear in the peak period, people can never be taken lightly.

          New Tang Dynasty Television Asia Taipei roundup


          Comment


          • #6
            Re: Surge in seasonal flu cases possible: CDC (Taiwan)

            Stil NOT dropped.

            Dropped it can be the avian flu one,
            but there were human seasonal flu variants emergencies now.


            #5 news text:

            "... dropped ..."

            "the currently popular type of influenza A, including H1 and H3 virus strains mutate, so that the effect of influenza vaccine decreased the protective effect may have been discounted , as the H1 virus prevalence has been 3 years, physicians express very unusual to remind everyone, the next two weeks may be the peak period of influenza transmission, a special attention"

            "an influenza pandemic situation"

            Comment


            • #7
              Re: Surge in seasonal flu cases possible: CDC (Taiwan)

              SEASONAL INFLUENZA, VACCINE MISMATCH - TAIWAN
              *********************************************
              A ProMED-mail post
              <http://www.promedmail.org>
              ProMED-mail is a program of the
              International Society for Infectious Diseases
              <http://www.isid.org>

              ******
              [1]
              Date: Tue 3 Feb 2009
              Source: Taiwan Times [edited]
              <http://www.etaiwannews.com/etn/news_content.php?id=855358〈=eng_news>


              Flu vaccines not as effective this year as in the past
              ------------------------------------------------------
              Influenza vaccines that proved to be effective late last year have
              failed to live up to expectations early this year, the Department of
              Health (DOH) said Tuesday [3 Feb 2009]. Chou Jih-haw, Deputy
              Director-general of the DOH's Centers for Disease Control, said more
              than 3.2 million free flu shots were given to the public in autumn
              and winter last year. "Judging from the number of influenza cases in
              the fourth quarter of 2008, it was significantly lower than in the
              same period the previous year," Chou said. "But this year, tests of
              flu viruses on the patients showed that the results have not been as
              good as expected," he continued.

              Chou said influenza vaccines given in autumn 2008 and this winter
              should be effective against the H1N1 and H3N2 viruses, and tests
              taken from patients who were inoculated last year proved their
              effectiveness. But in January [2009], tests found the vaccines did
              not work [were not protective?] on 70 percent of those with H1N1
              viruses and 40 percent of those with the H3N2 virus. A vaccine is
              considered effective if it controls the virus in 80 percent to 90
              percent of those inoculated. Chou would not categorize the vaccines
              as ineffective, however, because influenza viruses are "prone to
              mutation," meaning that the virus formula for producing vaccines must
              be changed on a yearly basis.

              A former CDC Director suggested Tuesday that part of the problem may
              be that flu viruses tend to strike Taiwan between 6 months and 2
              years earlier than European countries and the United States. Su
              Ih-jen, Director of the Division of Clinical Research of the National
              Health Research Institutes, said that because of the time lag,
              influenza vaccines produced by European and American pharmaceutical
              makers based on data provided by the World Health Organization could
              not keep up with the outbreak of flu in Asia. Su noted that with
              close exchanges between Taiwan and China, Taiwan has become an
              outpost of influenza outbreaks.

              The World Health Organization began to address the issue of different
              prevalent viruses in Asia and Europe last April [2008]. Currently, 2
              out of 5 major vaccine manufacturers have made inroads into China,
              and the production of Asian influenza vaccines "has become a trend,"
              he said. Su suggested that the virus in every influenza outbreak is
              slightly different, and that "it can show major changes about every 5
              years, so the effectiveness of vaccines can diminish."

              [Byline: Lilian Wu]

              --
              Communicated by:
              ProMED-mail
              <promed@promedmail.org>

              ******
              [2]
              Date: Thu 5 Feb 2009
              Source: Taipei Times [edited]
              <http://www.taipeitimes.com/News/taiw.../05/2003435334>


              Experts recommend switching to Asian-made flu vaccines
              ------------------------------------------------------
              Anticipating a bigger wave of flu infections caused by a form of the
              virus that has become resistant to medication and vaccines, doctors
              and academics urged the government to switch to Asian versions of the
              flu vaccine. Health officials last week said that with employees
              returning to work en masse after the Lunar New Year holiday, flu
              infections from increased human interaction in crowded places could
              spread fast.

              Fear of the flu heightened when the Centers for Disease Control (CDC)
              said on Tuesday [3 Feb 2009] that 2 strains of the influenza type A
              had mutated slightly and developed resistance to the flu medication
              Tamiflu [oseltamivir]. Tamiflu was still 30 percent effective in
              fighting the virus in October [2008], but the virus has recently
              developed 100 percent resistance against the drug, the CDC said.

              "The H1N1 strain [of the flu virus] has mutated into a form that is
              70 percent variant from the vaccine, and the H3N2 strain is 40
              percent variant," said CDC Deputy Director-general Chou Jih-haw,
              referring to the government-funded vaccine inoculation offered free
              of charge last year to children, the elderly and other high-risk
              groups. CDC statistics showed that influenza type A comprised about
              80 percent of all reported cases this winter. The type A H1N1 and
              H3N2 strains are currently circulating among flu victims.

              "The H1 strain is weaker than the H3 strain. Although the H1 strain
              may infect more people [because of its mutation], it is less likely
              to make patients critically ill," said Huang Li-min, a pediatrician
              at National Taiwan University Hospital.

              However, Huang said that he was not sure whether the H1N1 strain
              would mutate into a form that could result in critical conditions. He
              recommended that doctors prescribe 2 types of flu medication
              simultaneously, such as Tamiflu [oseltamivir] combined with
              amantadine, another type of flu treatment. This way, in case the
              virus strain has developed resistance to certain drugs, the
              medication may still be effective in controlling the disease, he said.

              The flu virus undergoes minor changes from time to time, and a major
              variant emerges about every 5 years, said Su Ih-jen, Director of the
              National Health Research Institute's division of clinical research.
              Su urged the government to switch from European-made vaccines to
              Asian-made ones, saying the latter was more "up to date" with new
              virus strains. "In 2005, we published research showing that the virus
              strains in Taiwan were 2 years ahead of Europe," he said. "We should
              be using Asian versions of the vaccine to stay up to date with the
              disease." In response, Chou said the CDC would assess the need to
              switch to the vaccines used in China, which he said would be more
              effective in combating the ever-changing virus.

              [Byline: Shelley Huang]

              --
              Communicated by:
              ProMED-mail
              <promed@promedmail.org>

              [Vaccine mismatch is being invoked to explain the relatively poorer
              protective response obtained by vaccination in Taiwan in the current
              year compared to that obtained in the preceding year. This is
              attributed to progressive change in the epidemic virus as a
              consequence of accumulation of mutations in the viral genome.
              According to the above reports previous research in Taiwan has
              suggested that: "virus strains in Taiwan were 2 years ahead of
              Europe." On this basis it is proposed that vaccines more in harmony
              with requirements in south and southeast Asia should be developed locally.

              Increasing resistance of current epidemic strains to the antiviral
              drugs Tamiflu and amantadine in Taiwan is considered to be another
              consequence of the mutability of the virus rather than a consequence
              of the enhanced use of these drugs in clinical practice. In contrast
              a recent study in Europe (Kramarz et al., Eurosurveillance, Vol. 14,
              Issue 5, 2009
              (<http://www.eurosurveillance.org/View...rticleId=19112>)
              based on analysis of prescription data concluded that while the
              precise relationship between oseltamivir [Tamiflu] use and resistance
              of influenza A(H1N1) to oseltamivir remains uncertain, the available
              data do not suggest a link between the rapid rise in the proportion
              of the resistant A(H1N1) and the use of oseltamivir in Europe. - Mod.CP]

              [A map showing the location of Taiwan is available at:
              http://www.worldatlas.com/webimage/countrys/asia/tw.htm> -CopyEd. EJP]

              [see also:
              2008
              ----
              Influenza vaccine 2009 (02): S. hemisphere 20080923.3009
              Influenza vaccine 2009: S. hemisphere 20080922.2988
              Influenza vaccine 2008/2009 - N. hemisphere 20080805.2404
              Influenza virus, 2007/2008 vaccine mismatch 20080209.0529
              Influenza virus, vaccine response: RFI 20080209.0528
              2007
              ----
              Influenza: update & vaccine composition 20070810.2607
              Influenza vaccine 2007/2008 - N Hemisphere 20070215.0566]
              -
              http://apex.oracle.com/pls/otn/f?p=2..._ID:1000,76025
              ------
              ...................cp/ejp/mpp

              Comment

              Working...
              X